Status:
RECRUITING
Dumping Syndrome and Esophageal Atresia
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Groupement Interrégional de Recherche Clinique et d'Innovation
french patient association for oesophageal atresia AFAO
Conditions:
Oesophageal Atresia
Dumping Syndrome
Eligibility:
All Genders
2-3 years
Phase:
NA
Brief Summary
Dumping syndrome (DS) is frequent in oesophageal atresia (29%). In causing hypoglycaemia, it can be dangerous for neonates. Mechanisms of DS are actually partialy understood. This is also an affection...
Eligibility Criteria
Inclusion
- Patients operated at birth for Oesophageal atresia type C
- Aged from 2 to 3 months at inclusion
- Off prokinetic treatment (suspended for at least 72 hours) before monitoring
Exclusion
- History of dumping syndrome of other cause (microgastria, fundoplication, dysautonomia..)
- History of any disease that can modify glycemic regulation (hyperinsulinism, neonatal diabete)
- Treatment that can modify gastric motility
Key Trial Info
Start Date :
February 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04522193
Start Date
February 23 2024
End Date
November 1 2026
Last Update
December 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Jeanne de Flandres
Lille, France, 59037
2
Hôpital Jeanne de Flandre - Pôle enfant, CHU de Lille
Lille, France